Fluocinolone_Acetonide: profile and news
(PZ) Medicis Announces FDA Approval of Broader Indication for ... Mar 2, 2006
TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, and SYNALAR(R) (fluocinolone acetonide), BUPHENYL(R ... - Houston Chronicle,
Uveitis Long Term Trial Results Positive for pSivida; Second Set ... Feb 21, 2006
Retisert(TM) is surgically implanted into the eye and is approved to release a constant amount of the drug, fluocinolone acetonide, over a treatment period of ... - Genetic Engineering News,
Diabetic Macular Edema trial with Retisert(TM); Positive Results ... Feb 21, 2006
DR. Retisert(TM) for DME is surgically implanted into the eye and releases a constant amount of the drug, fluocinolone acetonide. ... - Genetic Engineering News,
Diabetic Macular Edema trial with Retisert; Positive Results for ... Feb 22, 2006
DR. Retisert for DME is surgically implanted into the eye and releases a constant amount of the drug, fluocinolone acetonide. Retisert ... - Nanotechwire.com,
Bausch & Lomb Teams with Novartis Ophthalmics To Co-Promote Bausch ... Feb 9, 2006
...(NYSE: NVS), willco-promote Bausch & Lomb's patented orphan drug Retisert(TM)(fluocinolone acetonide intravitreal implant) 0.59 mg, in the UnitedStates. ... - Finanzen.net,
Bausch & Lomb Teams with Novartis Ophthalmics To Co-Promote Bausch ... 09 Feb 2006
...(NYSE: NVS), will co-promote Bausch & Lomb's patented orphan drug Retisert(TM) (fluocinolone acetonide intravitreal implant) 0.59 mg, in the United States. ... - Genetic Engineering News,
Medicis to Present at Merrill Lynch 17th Annual Global ... Feb 3, 2006
TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, and SYNALAR(R) (fluocinolone acetonide), BUPHENYL(R ... - Genetic Engineering News,
Alimera Sciences Names Proven Atlanta Executive Eiswirth New CFO Jan 25, 2006
2005 initiated a Phase III clinical trial to study diabetic macular edema (DME) patients treated using Medidur(TM) with fluocinolone acetonide, the company's ... - Canada NewsWire (press release),
Mississippi’s First Procedure with Retisert™ May Help Save Eye ... Jan 19, 2006
...& Lomb's Retisert ™, a tiny drug reservoir designed to deliver sustained level levels of the well-known corticosteroid fluocinolone acetonide directly to the ... - Emediawire (press release),
Saving Sight Dec 7, 2005
In April, the FDA approved a new treatment for chronic, non-infectious posterior uveitis, called Retisert™ (fluocinolone acetonide, by Bausch & Lomb). ... - WOWT,
Alimera Sciences Secures $31.8 Million in Series B Financing Nov 30, 2005
2005 initiated a Phase III clinical trial to study diabetic macular edema (DME) patients treated using Medidur(TM) with fluocinolone acetonide, the company's ... - PR Newswire (press release),
Medicis Board Unanimously Rejects Mentor Proposal Nov 20, 2005
TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, and SYNALAR(R) (fluocinolone acetonide), BUPHENYL(R ... - Business Wire (press release),
CDS launches Phase III trial for Retinal condition Oct 4, 2005
Sciences has initiated a Phase III clinical trial to study diabetic macular edema (DME) patients treated using Medidur™ to deliver fluocinolone acetonide. ... - Biotech Intelligence (press release),
Alimera Sciences, in Collaboration With Control Delivery Systems ... Oct 4, 2005
...initiated a Phase III clinical trial to study diabetic macular edema (DME) patients treated using Medidur(TM) with fluocinolone acetonide, the companies ... - CNW Telbec (Communiqués de presse),
pSivida buys US drug delivery firm for €87m Oct 4, 2005
And the two companies launched another implantable product – Retisert (fluocinolone acetonide) – to treat an inflammatory disease of the eye known as ... - in-PharmaTechnologist,
Bausch & Lomb Announces Medicare Reimbursement Terms for Retisert ... Oct 6, 2005
...that the Centers for Medicare & Medicaid Services has designated the single-indication orphan drug Retisert(TM) (fluocinolone acetonide intravitreal implant ... - Genetic Engineering News,
Medicis to Present at UBS Global Life Sciences Conference Sep 26, 2005
TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, and SYNALAR(R) (fluocinolone acetonide), BUPHENYL(R ... - PharmaLive.com (press release),
Medicis to Present at Thomas Weisel Partners Healthcare Tailwinds ... Sep 6, 2005
TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, and SYNALAR(R) (fluocinolone acetonide), BUPHENYL(R ... - Business Wire (press release),
